Diane D Liu

A predictive probability design for phase II cancer clinical trials

J Jack Lee, Diane D. Liu, Diane D Liu, 2008, Clinical trials.

Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery.

Ya-Chen Tina Shih, Jeffrey M Albert, Yu Shen, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Li Mao, Fadlo R Khuri, Diane D. Liu, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis

Humam Kadara, Diane D. Liu, Diane D Liu, 2011, Clinical Cancer Research.

Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience.

Funda Meric-Bernstam, Lajos Pusztai, Diane D. Liu, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Roy S Herbst, Diane D. Liu, Diane D Liu, 2007, Clinical Cancer Research.

hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.

Li Mao, Fadlo R Khuri, Diane D. Liu, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.

Mi-Kyoung Kim, B Nebiyou Bekele, Scott M Lippman, 2008, Cancer research.